Creyon Bio is the latest company to launch with artificial intelligence technology for drug R&D. The startup claims it’s technology can provide sufficient safety and toxicity to enable a therapy to bypass the animal research currently needed before clinical trials.
Triangle Inno - New AI biotech with Triangle lab aims $40M at precision medicines bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.
San Diego- and Research Triangle Park, NC-based Creyon Bio said Tuesday that it has raised $40M in a funding round. The funding was led by DCVC Bio and Lux Capital, along with Casdin Capital, Alexandria Vent
Creyon Bio Launches with $40 Million to Engineer Medicines on Demand for All globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.